OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia
Diletta Fontana, Carlo Gambacorti‐Passerini, Rocco Piazza
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 7
Diletta Fontana, Carlo Gambacorti‐Passerini, Rocco Piazza
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 7
Showing 7 citing articles:
Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Differential Diagnosis in the WHO and ICC 2022 Era: A Focused Review
Diletta Fontana, Elena Maria Elli, Fabio Pagni, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3175-3175
Open Access | Times Cited: 10
Diletta Fontana, Elena Maria Elli, Fabio Pagni, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3175-3175
Open Access | Times Cited: 10
Atypical CML: diagnosis and treatment
Massimo Breccia
Hematology (2023) Vol. 2023, Iss. 1, pp. 476-482
Closed Access | Times Cited: 6
Massimo Breccia
Hematology (2023) Vol. 2023, Iss. 1, pp. 476-482
Closed Access | Times Cited: 6
CCND2 mutations in atypical chronic myeloid leukemia: a report of two cases
Giovanni Iaquinta, Emilia Scalzulli, Silvia Angeloni, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2023) Vol. 64, Iss. 10, pp. 1730-1732
Closed Access | Times Cited: 4
Giovanni Iaquinta, Emilia Scalzulli, Silvia Angeloni, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2023) Vol. 64, Iss. 10, pp. 1730-1732
Closed Access | Times Cited: 4
ETNK1 mutation occurs in a wide spectrum of myeloid neoplasms and is not specific for atypical chronic myeloid leukemia
Wen Shuai, Zhuang Zuo, Nianyi Li, et al.
Cancer (2022) Vol. 129, Iss. 6, pp. 878-889
Closed Access | Times Cited: 7
Wen Shuai, Zhuang Zuo, Nianyi Li, et al.
Cancer (2022) Vol. 129, Iss. 6, pp. 878-889
Closed Access | Times Cited: 7
miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia
Pietro Poggio, Stefania Rocca, Federica Fusella, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Pietro Poggio, Stefania Rocca, Federica Fusella, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Atypical CML: Diagnosis and Therapy
Massimo Breccia
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, pp. S47-S48
Closed Access
Massimo Breccia
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, pp. S47-S48
Closed Access
Cytogenetics in the management of myeloproliferative neoplasms, mastocytosis and myelodysplastic/myeloproliferative neoplasms: Guidelines from the Group Francophone de Cytogénétique Hématologique (GFCH)
Matthieu Décamp, Émilie Klein, Catherine Godon, et al.
Current Research in Translational Medicine (2023) Vol. 71, Iss. 4, pp. 103424-103424
Closed Access
Matthieu Décamp, Émilie Klein, Catherine Godon, et al.
Current Research in Translational Medicine (2023) Vol. 71, Iss. 4, pp. 103424-103424
Closed Access
